Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.91
+0.05 (0.73%)
At close: Dec 5, 2025, 4:00 PM EST
6.89
-0.02 (-0.29%)
After-hours: Dec 5, 2025, 7:59 PM EST
Novavax Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Novavax stock have an average target of 10.78, with a low estimate of 6.00 and a high estimate of 19. The average target predicts an increase of 56.01% from the current stock price of 6.91.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Novavax stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 1 | 1 |
| Sell | 1 | 2 | 2 | 2 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 7 | 7 | 6 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell Maintains $7 → $6 | Sell | Maintains | $7 → $6 | -13.17% | Nov 18, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $18 → $16 | Strong Buy | Reiterates | $18 → $16 | +131.55% | Nov 10, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +1.30% | Nov 4, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $18 | Buy | Initiates | $18 | +160.49% | Oct 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +59.19% | Oct 23, 2025 |
Financial Forecast
Revenue This Year
1.08B
from 682.16M
Increased by 58.91%
Revenue Next Year
363.04M
from 1.08B
Decreased by -66.51%
EPS This Year
2.30
from -1.23
EPS Next Year
-0.47
from 2.30
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.2B | 592.5M | ||||
| Avg | 1.1B | 363.0M | ||||
| Low | 1.0B | 244.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 76.1% | -45.3% | ||||
| Avg | 58.9% | -66.5% | ||||
| Low | 50.4% | -77.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.20 | 0.41 | ||||
| Avg | 2.30 | -0.47 | ||||
| Low | 1.80 | -0.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | -82.2% | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.